Epidemiology/Health Services Research

Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?

  1. Alexandra Fouts1,
  2. Laura Pyle2,3,
  3. Liping Yu1,
  4. Dongmei Miao1,
  5. Aaron Michels1,
  6. Jeffrey Krischer4,
  7. Jay Sosenko5,
  8. Peter Gottlieb1,
  9. Andrea K. Steck1⇑, and
  10. the Type 1 Diabetes TrialNet Study Group
  1. 1Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO
  2. 2Department of Pediatrics, University of Colorado Denver, Aurora, CO
  3. 3Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO
  4. 4Pediatrics Epidemiology Center, University of South Florida, Tampa, FL
  5. 5University of Miami School of Medicine, Miami, FL
  1. Corresponding author: Andrea K. Steck, andrea.steck{at}ucdenver.edu.
Diabetes Care 2016 Oct; 39(10): 1738-1744. https://doi.org/10.2337/dc16-0302

Data supplements

Back to top
View Selected Citations (0)
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Add to Selected Citations

Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?
Alexandra Fouts, Laura Pyle, Liping Yu, Dongmei Miao, Aaron Michels, Jeffrey Krischer, Jay Sosenko, Peter Gottlieb, Andrea K. Steck, the Type 1 Diabetes TrialNet Study Group
Diabetes Care Oct 2016, 39 (10) 1738-1744; DOI: 10.2337/dc16-0302
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Jump to section